Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL
Clinical trial NCT06573151 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06573151
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2027-07-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.